cobas 4800 BRAF V600 Mutation Test for In Vitro Diagnostic Use Roche Molecular Systems, Inc., Product Usage: The primary use of the cobas 4800 BRAF V600 Mutation Test is the detection of the BRAF V600 mutations in DNA extracted from formalin-fixed, paraffin-embedded human melanoma tissue. It is intended to be used as an aid in selecting melanoma patients whose tumors carry BRAF V600 mutations for treatment with Zelboraf (vemurafenib).
Published November 7, 2012 · Recall initiated: July 31, 2012
Summary
FDA records medical device Class III recall Z-0188-2013, published November 7, 2012 and initiated July 31, 2012. Recalling firm: Roche Molecular Systems, Inc.; Status: Terminated; Reported quantity: 44 kits; Lot: Material number 05985595190; Lot number R03607. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
It was identified that BRAF controls dispositioned as "Internal Use Only" were incorrectly packaged into cobas 4800 BRAF V600 Mutation Test CE-IVD kit lot R03607 and released for distribution. Two control batches manufactured during two process validation studies are involved: PV7711: BRAF Mutant (MUT) Control PV0853: BRAF Wild Type (WT) Control
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Molecular Systems, Inc.
- Distributor
- Worldwide Distribution - Australia, Austria, Belgium, China, Hungary, Turkey and United Kingdom.
- Lot
- Material number 05985595190; Lot number R03607
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAcobas Liat Analyzer: respiratory virus panel nucleic acid assay system Catalog Number: 07341920190April 21, 2021
- FDANucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.April 4, 2018
- FDAcobas® Liat® AnalyzerJuly 27, 2016
- FDAcobas® PCR Urine Kit 100 PKT IVD cobas® PCR Female Swab Kit 100 PKT IVD cobas® PCR media 100T IVD cobas® PCRMarch 5, 2014
- FDAMerit Convenience Kits containing Cytosol Ophthalmics Balanced Salt Solution, 18 mL Single Dose Bottle, NDCNovember 14, 2012
- FDAARIA Radiation Oncology, Version 11. Varian Medical Systems, Palo Alto, CA. The ARIA Radiation OncologyNovember 7, 2012
Questions about this recall
Was cobas 4800 BRAF V600 Mutation Test for In Vitro Diagnostic Use Roche Molecular Systems, Inc., Product Usage: The primary use of the cobas 4800 BRAF V600 Mutation Test is the detection of the BRAF V600 mutations in DNA extracted from formalin-fixed, paraffin-embedded human melanoma tissue. It is intended to be used as an aid in selecting melanoma patients whose tumors carry BRAF V600 mutations for treatment with Zelboraf (vemurafenib). recalled?
Yes. FDA published recall Z-0188-2013 on November 7, 2012. Reported hazard: It was identified that BRAF controls dispositioned as "Internal Use Only" were incorrectly packaged into cobas 4800 BRAF V600 Mutation Test CE-IVD kit lot R03607 and released for distribution. Two control batches manufactured during two process validation studies are involved: PV7711: BRAF Mutant (MUT) Control PV0853: BRAF Wild Type (WT) Control
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail